Filters

Corina Penterling, Guido A Drexler, Claudia Böhland, Ramona Stamp, Christina Wilke, Herbert Braselmann, Randolph B Caldwell, Judith Reindl, Stefanie Girst, Christoph Greubel, Christian Siebenwirth, Wael Y Mansour, Kerstin Borgmann, Günther Dollinger, Kristian Unger, Anna A Friedl

PloS one 2017;11(6):e0156599

Free Full Text

Abstract

Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.

Mamoru Uemura, Hirofumi Yamamoto, Ichiro Takemasa, Koshi Mimori, Hideyuki Hemmi, Tsunekazu Mizushima, Masataka Ikeda, Mitsugu Sekimoto, Nariaki Matsuura, Yuichiro Doki, Masaki Mori

Clinical cancer research : an official journal of the American Association for Cancer Research 2011;16(18):4636-46

Full Text

Abstract

The Inhibition of Histone Lysine Demethylases Affects Head and Neck Cancer Cell Growth and Response to Cisplatin.

Dawid Dorna, Robert Kleszcz, Violetta Krajka-Kuźniak, Jarosław Paluszczak

Genes 2026;17(9):

Full Text

Abstract

Structure-based design and discovery of potent and selective KDM5 inhibitors.

Zhe Nie, Lihong Shi, Chon Lai, Shawn M O'Connell, Jiangchun Xu, Ryan K Stansfield, David J Hosfield, James M Veal, Jeffrey A Stafford

Bioorganic & medicinal chemistry letters 2018;28(9):1490-1494

Full Text

Abstract

Chemical basis for the recognition of trimethyllysine by epigenetic reader proteins.

Jos J A G Kamps, Jiaxin Huang, Jordi Poater, Chao Xu, Bas J G E Pieters, Aiping Dong, Jinrong Min, Woody Sherman, Thijs Beuming, F Matthias Bickelhaupt, Haitao Li, Jasmin Mecinović

Nature communications 2016;6():8911

Free Full Text

Abstract

Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.

Minran Zhou, Jiping Zeng, Xiaoming Wang, Xiangyu Wang, Tao Huang, Yue Fu, Ting Sun, Jihui Jia, Chunyan Chen

Oncotarget 2015;6(2):1249-61

Free Full Text

Abstract

Results: 1 – 15 / 17

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Retinoblastoma-Binding Protein 2""[mesh_terms]

Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin.

Pharmacological inhibition of KDM5A for cancer treatment.

Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212.

Vitamin C promotes pluripotency of human induced pluripotent stem cells via the histone demethylase JARID1A.

Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?).

Variable Phenotypes of Epilepsy, Intellectual Disability, and Schizophrenia Caused by 12p13.33-p13.32 Terminal Microdeletion in a Korean Family: A Case Report and Literature Review.

MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2.

Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis.

Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl Offspring.

Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair.

Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.

The Inhibition of Histone Lysine Demethylases Affects Head and Neck Cancer Cell Growth and Response to Cisplatin.

Structure-based design and discovery of potent and selective KDM5 inhibitors.

Chemical basis for the recognition of trimethyllysine by epigenetic reader proteins.

Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.

Results for
""Retinoblastoma-Binding Protein 2""[mesh_terms]